BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2680907)

  • 1. Properties of lymph-borne (veiled) dendritic cells in culture. II. Expression of the IL-2 receptor: role of GM-CSF.
    MacPherson GG; Fossum S; Harrison B
    Immunology; 1989 Sep; 68(1):108-13. PubMed ID: 2680907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of lymph-borne (veiled) dendritic cells in culture. I. Modulation of phenotype, survival and function: partial dependence on GM-CSF.
    MacPherson GG
    Immunology; 1989 Sep; 68(1):102-7. PubMed ID: 2680906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions.
    Wells JW; Darling D; Farzaneh F; Galea-Lauri J
    Scand J Immunol; 2005 Mar; 61(3):251-9. PubMed ID: 15787742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-mediated communication between dendritic epidermal T cells and Langerhans cells. In vitro studies using cell lines.
    Yokota K; Ariizumi K; Kitajima T; Bergstresser PR; Street NE; Takashima A
    J Immunol; 1996 Aug; 157(4):1529-37. PubMed ID: 8759735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant granulocyte-macrophage colony-stimulating factor down-regulates expression of IL-2 receptor on human mononuclear phagocytes by induction of prostaglandin E.
    Hancock WW; Pleau ME; Kobzik L
    J Immunol; 1988 May; 140(9):3021-5. PubMed ID: 3129507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.
    Gajewski TF; Goldwasser E; Fitch FW
    J Immunol; 1988 Oct; 141(8):2635-42. PubMed ID: 2971726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
    Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
    Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine-producing cell-stimulating activity. Interleukin 3 and granulocyte-macrophage colony-stimulating factor induce de novo synthesis of histidine decarboxylase in hemopoietic progenitor cells.
    Schneider E; Pollard H; Lepault F; Guy-Grand D; Minkowski M; Dy M
    J Immunol; 1987 Dec; 139(11):3710-7. PubMed ID: 2824613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of IL-2-driven T cell proliferation by recombinant human IL-3 and granulocyte-macrophage colony-stimulating factor.
    Santoli D; Clark SC; Kreider BL; Maslin PA; Rovera G
    J Immunol; 1988 Jul; 141(2):519-26. PubMed ID: 3290340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes.
    Conti L; Cardone M; Varano B; Puddu P; Belardelli F; Gessani S
    Eur J Immunol; 2008 Mar; 38(3):750-62. PubMed ID: 18236400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic ability of GM+IL-4 but not Flt3L-induced rat dendritic cells to promote allogeneic T cell hyporesponsiveness.
    Taieb A; Breitinger JJ; Unadkat JV; Shufesky WJ; Morelli AE; Thomson AW; Lee WP; Feili-Hariri M
    Clin Immunol; 2007 May; 123(2):176-89. PubMed ID: 17276735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
    Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.
    Vuckovic S; Fearnley DB; Mannering SI; Dekker J; Whyte LF; Hart DN
    Exp Hematol; 1998 Dec; 26(13):1255-64. PubMed ID: 9845382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells generated in the presence of GM-CSF plus IL-15 prime potent CD8+ Tc1 responses in vivo.
    Pulendran B; Dillon S; Joseph C; Curiel T; Banchereau J; Mohamadzadeh M
    Eur J Immunol; 2004 Jan; 34(1):66-73. PubMed ID: 14971031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype and functional identity of GM-CSF-independent dendritic cells generated by long-term propagation of DC progenitor cells in bone marrow cells and skin Langerhans cells.
    Katayama H; Hattori Y; Ogata K; Yan H; Satoh E; Teramoto K; Arii S; Kamide R; Nakagawa H; Kimura H
    Transplant Proc; 2005; 37(1):17-9. PubMed ID: 15808532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence.
    MacPherson GG; Jenkins CD; Stein MJ; Edwards C
    J Immunol; 1995 Feb; 154(3):1317-22. PubMed ID: 7822800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage factors which enhance the mixed leukocyte reaction initiated by dendritic cells.
    Naito K; Inaba K; Hirayama Y; Inaba-Miyama M; Sudo T; Muramatsu S
    J Immunol; 1989 Mar; 142(6):1834-9. PubMed ID: 2522129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth of an interleukin 2/interleukin 4-dependent T cell line induced by granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Kupper T; Flood P; Coleman D; Horowitz M
    J Immunol; 1987 Jun; 138(12):4288-92. PubMed ID: 2953804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed Langerhans cell and interstitial/dermal dendritic cell subsets emanating from monocytes in Th2-mediated inflammatory conditions respond differently to proinflammatory stimuli.
    Bechetoille N; André V; Valladeau J; Perrier E; Dezutter-Dambuyant C
    J Leukoc Biol; 2006 Jul; 80(1):45-58. PubMed ID: 16614258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.